Table 2.
COVID-19: characteristics of patients who developed COVID-19 infection
| COVID-19: positive test (number of patients: 13) | |||
| M/F, n (%) | 1 (7.7%)/12 (92.3%) | ||
| Age (years), mean ± SD (range) | 51.3 ± 5.9 (39–66) | ||
| Follow-up (months), mean ± SD (range) | 24.6 ± 24.7 (3.0–88.0) | ||
| Italian region of residence (number of patients: 13) | |||
| High exposure | 9 (69.2%) | ||
| Medium exposure | 2 (15.4%) | ||
| Low exposure | 2 (15.4%) | ||
| Comorbidities and follow-up (number of patients: 13) | |||
| PRE (13) | POST (13) | p | |
| BMI (kg/m2), mean ± SD (range) | 43.7 ± 3.6 (38.0–49.0) | 30.0 ± 5.0 (22.0–38.0) | p < 0.05 |
| Hypertension, n (%) | 9 (69.2%) | 4 (30.8%) | p < 0.05 |
| Diabetes mellitus, n (%) | 5 (38.5%) | 0 (0.0%) | p < 0.05 |
| GERD, n (%) | 11 (84.6%) | 8 (61.5%) | |
| Sleep apnea syndrome, n (%) | 4 (30.8%) | 0 (0.0%) | p < 0.05 |
| No comorbidities, n (%) | 0 (0.0%) | 4 (30.8%) | p < 0.05 |
SD standard deviation, LSG: laparoscopic sleeve gastrectomy, OAGB one-anastomosis gastric bypass, BMI body mass index, GERD gastroesophageal reflux disease